Peptides DB
Research-centric peptide and protocol reference hub
Study 9 of 41Erythropoietin (EPO) literaturebiorxiv-preprint · Observational2025

Unexpected functional role of the transactivation domain for nuclear import of STAT5

The transactivation domain of STAT5 plays a crucial role in its nuclear import following Epo stimulation, with specific amino acids identified as essential for this process.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the erythropoietin (epo) corpus
6
Preclinical
26
Observational · this one
1
Open-label
2
Randomised
6
Reviews

Summary and findings

This study investigates the role of the transactivation domain (TAD) in the nuclear import of STAT5 in HeLa EpoR cells. The researchers found that STAT5 mutants lacking the TAD were retained in the cytoplasm after Epo stimulation. A specific 12-amino-acid stretch within the TAD was identified as sufficient for restoring nuclear translocation.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2025

Abstract

The authors’ words, as biorxiv-preprint supplied them

Signal transducer and activator of transcription 5 (STAT5) is a key transcriptional regulator acting downstream of hematopoietic cytokines and hormones, such as erythropoietin (Epo), thrombopoietin or prolactin. STAT5-mediated gene regulation involves tyrosine phosphorylation at cytokine receptors and subsequent nuclear import. We studied STAT5 nucleocytoplasmic shuttling via live-cell imaging of fluorescent mutants in STAT5 -/- HeLa EpoR cells. Unexpectedly, STAT5 mutants lacking the transactivation domain (TAD) were retained in the cytoplasm following Epo stimulation. Building upon this, we identified a 12-amino-acid stretch in the TAD sufficient to restore nuclear translocation. Further analysis revealed two residues within this 12-amino-acid stretch, D754 and D758, to be essential for nuclear import of phosphorylated full-length STAT5. Importantly, a single intact TAD in the STAT5 dimer is sufficient for nuclear import. Our findings reveal a unique role of the TAD in STAT5 nuclear trafficking distinct from other STATs, providing new mechanistic insight and potential targets for therapeutic intervention in STAT5-driven disease such as myeloproliferative neoplasms and leukemia.

Elsewhere in the Erythropoietin (EPO) corpus

DErythropoietin beyond red blood cells: Systemic and oncological functions (Review).Molecular medicine reports · 2026reviewDSodium-Glucose Cotransporter 2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.JAMA · 2026 · Hemoglobin changed by 0.55 g/dL in the SGLT2 inhibitor group, P<0.001.reviewBResponsiveness to Erythropoiesis‑Stimulating Agents and Hemoglobin Variability in Japanese Patients With End‑Stage Kidney Diseasebiorxiv-preprint · 2026 · ERI was positively correlated with Hb-RSD (r = 0.473, p = 0.003).HumanBBlood Free Carnitine Level is an Independent Determinant of Erythrocyte Membrane Homogeneity and Osmotic Resistance in Maintenance Hemodialysis Patientsbiorxiv-preprint · 2026 · Higher FC levels were associated with increased OFT slope a (β=0.6090, P=0.036).HumanBGenetic mimicry of haematopoietic growth factor signalling: efficacy–safety trade-offs for cytopenias by drug-target Mendelian randomisationbiorxiv-preprint · 2026 · OR 0.65, 95% CI 0.49–0.86, P=0.0026 for lower thrombocytopenia risk with higher MPL expression.HumanCIn vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cellsbiorxiv-preprint · 2026 · >70% HbF-positive erythroid cells in treated miceAnimal